← All trials
NCT00411541
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 1995
- Primary completion
- —
- Completion date
- Jan 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 2600
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- International BFM Study GroupLead sponsor
- Grupo Argentinode TratamientoCollaborator
- Programa Nacional de Cancer Infantil de ChileCollaborator
- Government of AustriaCollaborator
- Programa Nacional de Cancer Infantil de ChileOverall official - principal investigator
- Government of AustriaOverall official - principal investigator
- Grupo Argentinode TratamientoOverall official - principal investigator
- Italian Association of Pediatric Hematology-OncologyOverall official - principal investigator
- Associazione Italiana Ematologia Oncologia PediatricaCollaborator
- European Organisation for Research and Treatment of CancerCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.